| Literature DB >> 36160016 |
Mohammad Saeed Kahrizi1, Indrajit Patra2, Abduladheem Turki Jalil3, Harun Achmad4, Samira Alesaeidi5, Moaed E Al-Gazally6, Sogol Alesaeidi7.
Abstract
Background: Several studies have revealed the negative effects of adiposity on telomere length shortening. However, the results of the studies assessing the negative relationship between obesity and leukocyte telomere length (LTL) are not consistent. This systematic review and meta-analysis are aimed to pool the results of articles assessing the relationship between obesity and LTL among children and adolescents.Entities:
Keywords: LTL; adolescents; children; leukocyte telomere length; obesity; youth
Year: 2022 PMID: 36160016 PMCID: PMC9490371 DOI: 10.3389/fgene.2022.861101
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
FIGURE 1Study flowchart.
The PICO criteria used for the systematic review.
| PICO criteria | Description |
|---|---|
| Participants | Children and adolescent population |
| Exposure (Interventions) | Children with overweight or obesity |
| Comparisons | Children without overweight or obesity |
| Outcome | Leukocyte telomere length as T/S ratio |
| Study design | Observational studies with the design of cross-sectional, case control or cohort studies with the baseline data of requested variables |
Risk of bias assessment using the Agency for Healthcare Research and Quality (AHRQ) checklist.
| ARHQ methodology checklist items for cross-sectional study | Todendi PF ( | Flannagan KS ( | Theall KP ( | Lamprokostopoulou a ( | Wojcicki JM ( | Zhu H ( | Al-Attas OS ( |
|---|---|---|---|---|---|---|---|
| 1) Define the source of information (survey, record review) | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ |
| 2) List the inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | ⊕ | U | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ |
| 3) Indicate the time period used for identifying patients | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ |
| 4) Indicate whether or not subjects were consecutive if not population-based | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ |
| 5) Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | U | U | U | U | U | ⊕ | U |
| 6) Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) | ⊕ | U | U | U | U | U | U |
| 7) Explain any patient exclusions from analysis | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | U | |
| 8) Describe how confounding was assessed and/or controlled | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ | ⊕ |
| 9) If applicable, explain how missing data were handled in the analysis | U | U | ⊕ | U | ⊕ | U | ⊕ |
| 10) Summarize patient response rates and completeness of data collection | U | U | ⊕ | ⊕ | ⊕ | U | U |
| 11) Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | ⊕ | U | U | U | U | U | U |
| Final score | 7 | 5 | 8 | 7 | 8 | 7 | 6 |
L, low risk of bias; H, high risk of bias; U, unclear risk of bias. The items were scored as follows: if the answer were “YES,” the score was “1” and if the answers were “NO” or “UNCLEAR”, the score was “0”. The final quality scores were: low quality = 0–3; moderate quality = 4–7 and high quality ≥8. ⊕, presence of the criteria, U, unclear.
Characteristics of the studies included in the meta-analysis owing to report the comparison of telomere length among obese and non-obese children and adolescence.
| First author/year | Journal/Country | Setting | Study population/Num | Age range (y) | Male % | Overweight/obesity status | Obesity criteria | Main finding |
|---|---|---|---|---|---|---|---|---|
| Todendi PF ( | Nutrition/Brazil | School | Healthy/981 | 7–17 | 44.03 | Overweight/obesity with 42% overweight | BMI for age Z score > +1SD, overweight; and >+2 SD obesity | No significant difference in telomere length between obese and non-obese children and adolescence |
| Flannagan KS ( | Eur J Nut/Colombia | School | Healthy/723 | 5–12 | 45.6 | Overweight/obesity | BMI for age Z score > +1SD, overweight; and >+2 SD obesity | Non- significant decrease and increase in telomere length with increased BMI among girls and boys respectively |
| Theall KP ( | Prev Med Rep/United States | Community | Healthy/90 | 5–16 | 46 | Overweight/obesity with 32% overweight | ≥85th and ≥95th percentile of BMI for overweight and obesity respectively | Non-significant decrease in telomere length among obese pediatric |
| Lamprokostopoulou A et al. ( | Eur J Clin Invest/Greece | School | Healthy/919 | 9–13 | 50.27 | Overweight/obesity with 30.03% overweight | BMI:25–29.9 and ≥30 kg/m2 for overweight and obesity respectively | Significantly lower telomere length in overweight and obese compared with non-obese children ( |
| Wojcicki JM ( | Am J Clin Nutr/United States | Community | Healthy/400 | 4–5 | 46.8 | Obesity | ≥85th and ≥95th percentile of BMI for overweight and obesity respectively | Non-significant shorter telomere length in obese versus non-obese children |
| Zhu H ( | Int J Obese/Georgia | Community | Healthy/766 | 14–18 | 50 | Overweight/obesity | ≥85th and ≥95th percentile of BMI for overweight and obesity respectively | Non-significant shorter telomere length in obese versus non-obese adolescents |
| Al-Attas OS ( | Acta Pædiatrica/Saudi Arabia | Community | Healthy/148 | 5–12 | 46.6 | Obesity | BMI:25–29.9 and ≥30 kg/m2 for overweight and obesity respectively | Significantly lower LTL among obese boys ( |
The study by Todendi PF et al. (Todendi et al., 2020) was performed in children and adolescence separately so the results were included as two independent studies. The studies by Flannagan KS et al (Flannagan et al., 2020) and Al-Attas OS (Al-Attas et al., 2010) were included as two independent studies among boys and girls. The study by Lamprokostopoulou A et al. (Wojcicki et al., 2016b) was included as two independent studies in overweight and obese individuals. The study by Wojcicki JM et al. (Wojcicki et al., 2016a), was performed in two different age groups of 4 and 5 years old, thus, the results were included as two independent studies. All of the studies were conducted in combination of both genders and had cross-sectional design. LTL assessment was based on modified quantitative polymerase chain reaction polymorphism q (PCR) and was expressed as relative ratio of telomere repeat copy number (T) to single copy gene copy number (S) or T/S ratio.
FIGURE 2Weighted mean difference (WMD) with a 95% confidence interval (CI) of the comparison of leukocyte telomere length (LTL) in children and adolescents with or without overweight/obesity.
Results of subgroup analyses of the comparison of leukocyte telomere length (LTL) in overweight/obese versus non-overweight/obese youth.
| Group | No. of studies | WMD (95%CI) | P | P heterogeneity | I2, % | P between study heterogeneity |
|---|---|---|---|---|---|---|
| Total | 12 | −0.081 −0.137 −0.026 | 0.004 | <0.001 | 99.9 | |
| Weight status | <0.001 | |||||
| Overweight + Obese | 8 | −0.075 −0.254 0.104 | 0.049 | <0.001 | 96.6 | |
| Obese | 4 | −0.061 −0.151 0.030 | 0.087 | <0.001 | 99.3 | |
| Continent | <0.001 | |||||
| United States | 8 | −0.052 −0.119 0.014 | 0.124 | <0.001 | 98.7 | |
| Europe | 2 | −0.185 −0.214 −0.156 | <0.001 | <0.001 | 99.8 | |
| Asia | 2 | −0.084 −0.310 0.141 | 0.463 | <0.001 | 99.5 | |
| Baseline LTL (T/S ratio) | <0.001 | |||||
| ≤1 | 6 | −0.131 −0.200 −0.062 | <0.001 | <0.001 | 100 | |
| >1 | 6 | −0.035 −0.090 0.020 | 0.216 | <0.001 | 97.5 | |
| Sample size | <0.001 | |||||
| ≤100 | 3 | −0.156 −0.391 0.078 | 0.192 | <0.001 | 99.8 | |
| 100–400 | 5 | −0.008 −0.019 0.004 | 0.199 | 0.871 | - | |
| >400 | 4 | −0.099 −0.180 −0.017 | 0.018 | <0.001 | 100 | |
| Quality score | <0.001 | |||||
| 5–6 | 4 | −0.045 −0.197 0.107 | 0.564 | <0.001 | 98.4 | |
| 7–9 | 8 | −0.098 −0.158 −0.038 | 0.001 | <0.001 | 100 | |
| Gender | <0.001 | |||||
| Both | 8 | −0.098 −0.158 −0.038 | 0.001 | <0.001 | 100 | |
| Boys | 2 | −0.091 −0.316 0.134 | 0.427 | <0.001 | 93.6 | |
| Girls | 2 | 0.029 0.014 0.044 | <0.001 | 0.311 | 2.5 | |
| Age range | <0.001 | |||||
| Children | 2 | −0.007 −0.019 0.004 | 0.214 | 0.707 | 0 | |
| Adolescents | 1 | −0.010 −0.013 −0.007 | <0.001 | - | - | |
| Children + adolescents | 9 | −0.121 −0.161 −0.082 | <0.001 | <0.001 | 99.8 | |
| Setting | <0.001 | |||||
| School | 7 | −0.072 −0.139 −0.005 | 0.035 | <0.001 | 100 | |
| Community | 5 | −0.097 −0.200 0.006 | 0.065 | <0.001 | 99.5 | |
| Obesity criteria | <0.001 | |||||
| BMI-Z score for age | 4 | −0.006 −0.054 0.042 | 0.808 | 0.766 | 0 | |
| BMI percentile | 4 | −0.081 −0.171 0.008 | 0.075 | <0.001 | 99.5 | |
| BMI | 4 | −0.184 −0.214 −0.155 | <0.001 | <0.001 | 99.5 |
Note that because all of included studies had cross-sectional designs and telomere length was assessed by qPCR, thus, subgrouping according to these parameters were not performed. Also, note that the study by Todendi PF (Todendi et al., 2020) was performed in children and adolescence; the studies by Flannagan KS et al. (Flannagan et al., 2020) and Al-Attas OS (Al-Attas et al., 2010) were performed separately in boys and girls; The study by Lamprokostopoulou A et al. (Wojcicki et al., 2016b) was performed seperaely among overweight.
Meta regression approach in the two-class meta-analysis.
| Hypertension (HTN) | Tau2 |
| 95% CI |
|---|---|---|---|
| Estimate of between-study variance | 0.0509 | ||
| By weight status (obese or not) | 0.0602 | 0.39 | (−0.08, 0.20) |
| By continent (United States or not) | 0.0415 | 0.57 | (−0.11, 0.20) |
| By baseline telomere as T/S ratio (>1 or not) | −0.1221 | 0.06 | (−0.25, 0.08) |
| By sample size (>400 or not) | −0.0365 | 0.62 | (−0.19, 0.12) |
| By quality score (>7 or not) | −0.0865 | 0.27 | (−0.25, 0.07) |
| By gender (both or not) | −0.0865 | 0.28 | (−0.25, 0.07) |
| By age (0–18 years or not) | −0.1094 | 0.10 | (−0.24, 0.02) |
| By setting (school or not) | 0.0159 | 0.83 | (−0.14, 0.17) |
| By Obesity criteria (BMI-for age Z score) | −0.131 |
| (−0.25, -0.10) |
Statistically significant and less than 0.05 p-values are in bold.
FIGURE 3Begg’s funnel plot [(with pseudo 95% confidence intervals (CIs)] of the weighted mean difference (WMD) versus the standard error (se) of WMD for the comparison of LTL in children and adolescents with or without overweight/obesity (P begg = 0.583; P egger = p = 0.261).
FIGURE 4Mechanistic pathways of the possible effects of obesity on leukocyte telomere length shortening among children and adolescents (TL, telomere length; NCD, non-communicable disease).